Tom Y. Lee - 30 Sep 2022 Form 4 Insider Report for PURE BIOSCIENCE, INC. (PURE)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Tom Lee
Issuer symbol
PURE
Transactions as of
30 Sep 2022
Net transactions value
$0
Form type
4
Filing time
04 Oct 2022, 16:24:42 UTC
Previous filing
19 Jul 2022
Next filing
19 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PURE Stock Option (Right to Buy) Award $0 +125,000 $0.000000 125,000 30 Sep 2022 Common Stock 125,000 $0.2000 Direct F1
transaction PURE Stock Option (Right to Buy) Award $0 +200,000 $0.000000 200,000 30 Sep 2022 Common Stock 200,000 $0.2000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024.
F2 The option shares shall vest and become exercisable in four equal installments December 30, 2022, March 30, 2023, June 30, 2023, and September 30, 2023.